NEYPPC Pharmacy - Unlicensed Imported Medicines (wave 2)
Leeds Teaching Hospitals NHS Trust
- Value
- £43,314,823.84
- Published
- 13 Oct 2026
- Deadline
- 30 Nov 2026
- Procedure
- Competitive flexible procedure
- Category
- 33600000 — Pharmaceutical products
- Location
- Leeds, UKE42, LS1 3EX, United Kingdom
- Notice reference
- 096479-2026
Requirements summary
The North East and Yorkshire NHS Pharmaceutical Purchasing Consortium, with Leeds Teaching Hospitals NHS Trust listed as buyer, is establishing a closed framework agreement for unlicensed imported medicines, including products needing over-labelling and translation. The framework supplies NHS and eligible public bodies where licensed alternatives cannot meet patient needs. Estimated value is GBP 36,095,686.53 net (GBP 43,314,823.84 gross), with a contract period from 1 May 2027 to 31 December 2028 and an optional 12-month extension.
Key requirements
- Suppliers must hold all relevant MHRA licences, authorisations and approvals to import, distribute and supply unlicensed medicines in the UK
- Suppliers must demonstrate compliance with applicable GMP and GDP standards
- Framework must supply unlicensed imported medicines, including products requiring over-labelling and translation
- Medicines must be imported under Regulation 167 of the Human Medicines Regulations 2012 where no suitable licensed alternative exists
- Evaluation weighting: 60% commercial (price), 30% technical quality, 10% social value and sustainability
- Contract runs 1 May 2027 to 31 December 2028, with optional 12-month extension to 31 December 2029